REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 152 filers reported holding REATA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $989,391 | +188.8% | 10,882 | +20.7% | 0.06% | +160.9% |
| Q4 2022 | $342,556 | +57.1% | 9,017 | +3.8% | 0.02% | +64.3% |
| Q3 2022 | $218,000 | -26.8% | 8,686 | -11.5% | 0.01% | -12.5% |
| Q2 2022 | $298,000 | -44.3% | 9,818 | -39.9% | 0.02% | -42.9% |
| Q1 2022 | $535,000 | +38.2% | 16,328 | +497.4% | 0.03% | +33.3% |
| Q2 2021 | $387,000 | -24.4% | 2,733 | -46.8% | 0.02% | -27.6% |
| Q1 2021 | $512,000 | -5.7% | 5,137 | +16.9% | 0.03% | -25.6% |
| Q4 2020 | $543,000 | -56.9% | 4,395 | -66.0% | 0.04% | -4.9% |
| Q3 2020 | $1,259,000 | +517.2% | 12,921 | +441.5% | 0.04% | +925.0% |
| Q1 2019 | $204,000 | – | 2,386 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $110,053,269 | 27.64% |
| Ghost Tree Capital, LLC | 500,000 | $18,995,000 | 8.11% |
| First Light Asset Management, LLC | 2,062,453 | $78,352,589 | 7.27% |
| Boxer Capital, LLC | 1,230,004 | $46,727,852 | 2.46% |
| Sofinnova Investments, Inc. | 992,029 | $37,687,182 | 2.24% |
| Tri Locum Partners LP | 141,466 | $5,374,000 | 2.17% |
| MPM BioImpact LLC | 194,181 | $7,376,936 | 1.91% |
| Ikarian Capital, LLC | 201,200 | $7,643,588 | 1.84% |
| KRS Capital Management, LLC | 28,141 | $1,069,077 | 1.46% |
| EMERALD ADVISERS, LLC | 679,772 | $25,824,538 | 1.25% |